Atorvastatin was demonstrated to inhibit phosphorylation of STAT1 imposed by IFNγ in mononuclear cells of multiple myeloma patients; hence, we were convinced to find its effect on PD-L1 expression in HepG2 cells in this study [18]. This evidence concerns the gene IFNG and AL amyloidosis.